It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Identification and characterization of novel unknown viruses is of great importance. The introduction of high-throughput sequencing (HTS)-based methods has paved the way for genomics-based detection of pathogens without any prior assumptions about the characteristics of the organisms. However, the use of HTS for the characterization of viral pathogens from clinical samples remains limited. Here, we report the identification of a novel Orthobunyavirus species isolated from horse plasma. The identification was based on a straightforward HTS approach. Following enrichment in cell culture, RNA was extracted from the growth medium and rapid library preparation, HTS and primary bioinformatic analyses were performed in less than 12 hours. Taxonomical profiling of the sequencing reads did not reveal sequence similarities to any known virus. Subsequent application of de novo assembly tools to the sequencing reads produced contigs, of which three showed some similarity to the L, M, and S segments of viruses belonging to the Orthobunyavirus genus. Further refinement of these contigs resulted in high-quality, full-length genomic sequences of the three genomic segments (L, M and S) of a novel Orthobunyavirus. Characterization of the genomic sequence, including the prediction of open reading frames and the inspection of consensus genomic termini and phylogenetic analysis, further confirmed that the novel virus is indeed a new species, which we named Ness Ziona virus.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Israel Institute for Biological Research, Department of Biochemistry and Molecular Genetics, Ness Ziona, Israel (GRID:grid.419290.7) (ISNI:0000 0000 9943 3463)
2 Israel Institute for Biological Research, Department of Infectious Diseases, Ness Ziona, Israel (GRID:grid.419290.7) (ISNI:0000 0000 9943 3463)
3 Israel Institute for Biological Research, Department of Biotechnology, Ness Ziona, Israel (GRID:grid.419290.7) (ISNI:0000 0000 9943 3463)
4 Hadassah Hebrew University Medical Center, Clinical Virology Unit, Jerusalem, Israel (GRID:grid.17788.31) (ISNI:0000 0001 2221 2926)
5 Israel Institute for Biological Research, Ness Ziona, Israel (GRID:grid.419290.7) (ISNI:0000 0000 9943 3463)